Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Journal of Clinical Microbiology|February 4, 2006
Two new colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureusAhmet Y Coban, Bülent Bozdogan, Cigdem Cekic Cihan, et al.
The Journal of Antimicrobial Chemotherapy|March 9, 2012
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftarolineRodrigo E Mendes, Athanassios Tsakris, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agentsFrederick A Browne, Bülent Bozdogan, Catherine Clark, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, TexasSusana Chavez-Bueno, Bülent Bozdogan, Kathy Katz, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporinKlaudia Kosowska, Dianne B Hoellman, Gengrong Lin, et al.
Diagnostic Microbiology and Infectious Disease|December 11, 2007
Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clonesMasaaki Ikenaga, Klaudia Kosowska-Shick, Kenji Gotoh, et al.
BMC Microbiology|July 31, 2008
Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureus strainsArtur J Sabat, Benedykt Wladyka, Klaudia Kosowska-Shick, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2003
Antimicrobial susceptibility and macrolide resistance inducibility of Streptococcus pneumoniae carrying erm(A), erm(B), or mef(A)George A Syrogiannopoulos, Ioanna N Grivea, Lois M Ednie, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzaeKlaudia Kosowska, Kim Credito, Glenn A Pankuch, et al.
Antimicrobial Agents and Chemotherapy|July 11, 2007
Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditisKathleen Julian, Klaudia Kosowska-Shick, Cynthia Whitener, et al.
Pageof 14